Cargando…
Gene Therapy for Neuromuscular Diseases: Health Economic Challenges and Future Perspectives
Highly efficacious, potentially curative gene therapies holds immense clinical promise, but also present complex challenges. At the time of regulatory approval and health technology assessment (HTA), evidence of efficacy and safety of gene therapies is often uncertain. In addition, research, develop...
Autor principal: | Landfeldt, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697054/ https://www.ncbi.nlm.nih.gov/pubmed/36314216 http://dx.doi.org/10.3233/JND-221540 |
Ejemplares similares
-
Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2019) -
Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
por: Gomez Limia, Cintia, et al.
Publicado: (2022) -
Enzyme Therapy: Current Challenges and Future Perspectives
por: de la Fuente, Miguel, et al.
Publicado: (2021) -
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
por: Lopes-Coelho, Filipa, et al.
Publicado: (2021) -
The Liver as a Target Organ for Gene Therapy: State of the Art, Challenges, and Future Perspectives
por: Jacobs, Frank, et al.
Publicado: (2012)